Myriad Genetics MYGN Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's invested capital?
- Myriad Genetics (MYGN) reported invested capital of $422.9M in Q1 2026.
- How has Myriad Genetics's invested capital changed year-over-year?
- Myriad Genetics's invested capital decreased by 44.5% year-over-year, from $761.5M to $422.9M.
- What is the long-term trend for Myriad Genetics's invested capital?
- Over 5 years (2020 to 2025), Myriad Genetics's invested capital has grown at a -16.5% compound annual growth rate (CAGR), from $1.05B to $426.5M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).